These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 37778903)
61. Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series. Wan EYF; Wang Y; Chui CSL; Mok AHY; Xu W; Yan VKC; Lai FTT; Li X; Wong CKH; Chan EWY; Lau KK; Cowling BJ; Hung IFN; Wong ICK Lancet Healthy Longev; 2022 Jul; 3(7):e491-e500. PubMed ID: 35813276 [TBL] [Abstract][Full Text] [Related]
62. Strategies and safety considerations of booster vaccination in COVID-19. Meng H; Mao J; Ye Q Bosn J Basic Med Sci; 2022 Jun; 22(3):366-373. PubMed ID: 35366790 [TBL] [Abstract][Full Text] [Related]
63. Effect of psychotropics on the risk of COVID-19 in middle-aged and older adults. Ma Y; Li S; Yang H; Zhang Y; Li H; Xu F; Hou Y; Zhang X; Wang Y Eur Neuropsychopharmacol; 2023 Jan; 66():67-77. PubMed ID: 36463771 [TBL] [Abstract][Full Text] [Related]
64. Mass testing after a single suspected or confirmed case of COVID-19 in London care homes, April-May 2020: implications for policy and practice. Tang S; Sanchez Perez M; Saavedra-Campos M; Paranthaman K; Myers R; Fok J; Crawley-Boevey E; Dun-Campbell K; Janarthanan R; Fernandez E; Vusirikala A; Patel B; Ma T; Amin-Chowdhury Z; Shetty N; Zambon M; Bell A; Wynne-Evans E; Chow Y; Ladhani S Age Ageing; 2021 May; 50(3):649-656. PubMed ID: 33620453 [TBL] [Abstract][Full Text] [Related]
65. Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population. Bichara CDA; da Silva Graça Amoras E; Vaz GL; da Silva Torres MK; Queiroz MAF; do Amaral IPC; Vallinoto IMVC; Bichara CNC; Vallinoto ACR BMC Infect Dis; 2021 May; 21(1):443. PubMed ID: 33992073 [TBL] [Abstract][Full Text] [Related]
66. Association of Glucose-6-Phosphate Dehydrogenase Deficiency With Outcomes in US Veterans With COVID-19. Elsea SH; Razjouyan J; Lee KM; Lynch JA; Martini S; Pandit LM JAMA Netw Open; 2023 Mar; 6(3):e235626. PubMed ID: 36988953 [TBL] [Abstract][Full Text] [Related]
67. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771 [TBL] [Abstract][Full Text] [Related]
68. Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People. Demaret J; Corroyer-Simovic B; Alidjinou EK; Goffard A; Trauet J; Miczek S; Vuotto F; Dendooven A; Huvent-Grelle D; Podvin J; Dreuil D; Faure K; Deplanque D; Bocket L; Duhamel A; Labreuche J; Sobaszek A; Hisbergues M; Puisieux F; Labalette M; Lefèvre G Front Immunol; 2021; 12():778679. PubMed ID: 34868051 [TBL] [Abstract][Full Text] [Related]
69. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study. Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD; Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524 [TBL] [Abstract][Full Text] [Related]
70. Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study. Tut G; Lancaster T; Sylla P; Butler MS; Kaur N; Spalkova E; Bentley C; Amin U; Jadir A; Hulme S; Ayodele M; Bone D; Tut E; Bruton R; Krutikov M; Giddings R; Shrotri M; Azmi B; Fuller C; Baynton V; Irwin-Singer A; Hayward A; Copas A; Shallcross L; Moss P Lancet Healthy Longev; 2022 Jul; 3(7):e461-e469. PubMed ID: 35813280 [TBL] [Abstract][Full Text] [Related]
71. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study. Huang C; Wei Y; Yan VKC; Ye X; Kang W; Yiu HHE; Shami JJP; Cowling BJ; Tse ML; Castle DJ; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Hayes JF; Chang WC; Chung AKK; Lau CS; Wong ICK; Chan EW Lancet Psychiatry; 2023 Jun; 10(6):403-413. PubMed ID: 37141907 [TBL] [Abstract][Full Text] [Related]
72. The peculiarities of COVID-19 in older people: Considerations after two years. Trevisan C; Okoye C; Antonelli Incalzi R; Eur J Intern Med; 2023 Nov; 117():45-49. PubMed ID: 37778903 [No Abstract] [Full Text] [Related]
73. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
74. The report from ASFA COVID-19 taskforce: Considerations and prioritization on apheresis procedures during the SARS-CoV-2 coronavirus disease (COVID-19) pandemic. Yamada C; Hofmann JC; Witt V; Gupta GK; Winters JL; J Clin Apher; 2021 Dec; 36(6):878-881. PubMed ID: 34510542 [TBL] [Abstract][Full Text] [Related]